Salute e Benessere

Monthly information related to total number of voting rights and shares…

Monthly information related to total number of voting rights and shares composing the share capital _June 26 , 2023 .Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – FranceListing markets:Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com DateTotal of shares composing the share...
Nasdaq GlobeNewswire
27/06/2023

The Kennedy Forum Founder and Former U.S. Congressman Patrick J. Kennedy…

Before his remarks to the World Health Organization, Congressman Kennedy spoke to students, alumni, and faculty at the Oxford Union in the United Kingdom. He then addressed global leaders at the SNF Nostos Conference in Greece, where he also met with former U.S. President Barack Obama. The Kennedy Forum's Co-Founder and staunch advocate for youth mental health, Amy Kennedy, also participated in SNF's Suicide Prevention panel: Safeguarding the emotional health of teens and young adults, on…
PR Newswire
27/06/2023

AIM ImmunoTech Announces Publication of Positive Findings from a Pre-Clinical…

Findings support efforts in ongoing Early Access Program and upcoming clinical trials, and suggest Ampligen's potential to reduce tumor cell growth and boost immune response in pancreatic cancer patients with sufficient tumor levels of TLR-3 AIM ImmunoTech Inc.(NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of its TLR-3 agonist Ampligen (rintatolimod) as a novel and potentially powerful therapeutic in locally advanced...
Nasdaq GlobeNewswire
27/06/2023

Transactions in connection with share buy-back program

Company announcement no. 32 - 2327 June 2023 Transactions in connection with share buy-back program On 8 May 2023 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company announcement no. 17 - 23. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules...
Nasdaq GlobeNewswire
27/06/2023

Assisted Reproductive Technology Market Zooms Towards Billion-Dollar Valuation…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=12269 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=12269 Browse in-depth TOCon" Assisted Reproductive Technology Market " 202 - Pages 126 – Tables 37 – Figures Assisted Reproductive Technology Market Poised for Remarkable Growth Driven by Technological Advancements The global Assisted Reproductive Technology (ART) Market is set to experience...
PR Newswire
27/06/2023

Revolutionizing Oral Care: Global Dental Consumables Market Holds a Whopping $45…

The demand for dental consumables is increasing globally to treat and diagnose various dental problems including tissue problems, dental caries, dental impairment, and others. The increasing focus on physical appearance is driving the demand for dental consumables to perform cosmetic dentistry, which is expected to propel the growth of the market. The demand for dental consumables is increasing globally to treat and diagnose various dental problems including tissue problems, dental caries,...
PR Newswire
27/06/2023

LifeArc strengthens Board of Trustees with new appointments

LifeArcstrengthens Board of Trustees with newappointments 27 June 2023 : LifeArc, the self-funded medical research organisation, announces today that Dr Terri Cooper, Dr Sameer Mistry and Dr Rima Makarem have joined the Board of Trustees as Non-Executive Directors, effective from 27 June 2023. Dr Terri Cooper, a retired Principal of Deloitte's US consulting practice is a 35-year life sciences-healthcare veteran. She led Deloitte's global healthcare sector and built the...
Nasdaq GlobeNewswire
27/06/2023

X-trodes awarded €5.2M Funding from European Innovation Council (EIC) to Advance…

By leveraging this groundbreaking technology, X-trodes is paving the way for a new era of home sleep monitoring. Our innovative solution empowers physician, sleep experts and even the individuals to track sleep patterns and vital physiological signals, eliminating the need for restrictive laboratory environments. This breakthrough brings unparalleled convenience and accuracy to sleep monitoring, revolutionizing the field and providing valuable insights for both individuals and healthcare…
PR Newswire
27/06/2023

Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine…

Booster study successfully met its primary objective, demonstrating non-inferiority to mRNA-vaccine Regulatory pathway will depend upon the outcome of secondary endpoints, reporting in the third quarter of 2023COPENHAGEN, Denmark, June 27, 2023– Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a Phase 3 non-inferiority clinical trial of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 booster vaccine candidate.The two-part study enrolled a total of 4,205 adults who...
Nasdaq GlobeNewswire
27/06/2023

Shareholders Approve all Board Proposals at Today's Annual General Meeting

Pratteln, Switzerland, June 27, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved all motions by the Board of Directors at the Annual General Meeting (AGM) held today in Pratteln, Switzerland , with a large majority . Participating shareholders represented a total of 26'037'561 shares or 20.7% of the Company's share capital .Approval of the 2022 Annual Report and discharge of corporate bodiesThe shareholders approved the Annual Report,...
Nasdaq GlobeNewswire
27/06/2023

TMRW Life Sciences Names Louis Villalba Chief Executive Officer

"As the mother of a daughter born through IVF, I remain passionate about the need for technology-enabled innovation in this field, bringing clear benefits to both patients and clinics. TMRW is revolutionizing an entire industry, delivering new levels of transparency, safety and scalability to benefit millions of future families and hopeful parents," said Comonte. "I'm grateful to have had the opportunity to lead this incredible team and I look forward to working with TMRW as a…
PR Newswire
27/06/2023

AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active…

AC ImmuneReceives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy ,ACI-24.060, to Treat Alzheimer's DiseaseOngoing Phase 1b/2 ABATE study enrolling well and expanding to sites in USA with Investigational New Drug (IND) clearance for ACI-24.060Dosed first individual with Down syndrome (DS) in the DS cohort of ABATEInterim safety and immunogenicity data in Alzheimer's disease (AD) and DS cohorts expected in H2 2023Initial PET data on amyloid...
Nasdaq GlobeNewswire
27/06/2023

Empowering the Future of Pain Relief Research: Recipients of the 2023…

More than 1.5 billion individuals suffer from chronic pain – almost one in five people worldwide.[1] Chronic Pain is one of the most common reasons for seeking medical help. It is also a frequent cause of people withdrawing from the labor market early and significantly contributing to disability retirement.2 It is associated with multiple conditions, and many patients struggle to find effective pain relief. More than 1.5 billion individuals suffer from chronic pain – almost one in five people...
PR Newswire
27/06/2023

Pain Management Devices Market to be Worth $14.14 Billion by 2030: Grand View…

Read full market research report with ToC for more Insights, "Pain Management Devices Market Size, Share & Trends Analysis Report By Application (Neuropathic, Cancer), By Product (RFA, Neurostimulation), By Region (North America, Asia Pacific), And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read full market research report with ToC for more Insights, " Pain Management Devices Market Size, Share & Trends Analysis Report By Application (Neuropathic…
PR Newswire
27/06/2023

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership

WuXi Biologics is a leading global CRDMO company. Leveraging its comprehensive open-access platform, WuXi Biologics provides end-to-end research, development and manufacturing services for monoclonal antibodies, bispecifics, ADCs, vaccines and other biological drugs to its global clients. Since 1986, Pharmadule Morimatsu has successfully delivered more than 80 modular facilities to the pharmaceutical and biopharmaceutical industries worldwide. In recent years, Pharmadule Morimatsu has delivered…
PR Newswire
27/06/2023

PM International celebrates its 30th anniversary

On Saturday, the 30th Anniversary World Congress in the SAP Arena followed. The anniversary event began with the appearance of company CEO and Founder Rolf Sorg. In his speech, Rolf Sorg reviewed the 30-year history of PM-International and invited numerous guests to the stage who played important roles in the development of PM-International. Afterwards, in front of the sold-out stadium audience, he recognized the team effort behind the globally growing successful company. "The success of…
PR Newswire
27/06/2023

"QuadratyxAI Revolutionizes Healthcare with Advanced AI Tools: Predictive…

George Molakal, North American Director of QuadratyxAI, shared his vision for the role of AI in healthcare, saying, "Healthcare performance is highly dependent on integrating AI and digitalization into all aspects of patient care. This integration is key to achieving comprehensive patient outcomes, increasing the profitability of hospitals and clinics by 20% and revenues by 70%. Hospitals using AI will lead the healthcare revolution in the next decade." George Molakal, North American…
PR Newswire
27/06/2023

MinervaX Announces Completion of Enrolment in Phase I Clinical Vaccine Trial as…

To tackle this issue MinervaX has expanded the development pipeline of its novel GBS vaccine to include older adults, addressing the global burden and urgent need for the development of a vaccine to prevent and reduce deaths associated with GBS across the population. In pregnant women. MinervaX is currently progressing two Phase II clinical vaccine trials for the prevention of life-threatening infections in newborns. The trials are demonstrating that the vaccine has an acceptable safety profile…
PR Newswire
27/06/2023

Hospital in the Netherlands selects Sectra's subscription model for enterprise…

Amstelland Hospital is a general hospital located in Amstelveen, the Netherlands. It offers a wide range of medical services, including emergency care, surgery, radiology, cardiology, and rehabilitation. The hospital has over 200 beds and employs around 1,100 healthcare professionals. Amstelland Hospital is a general hospital located in Amstelveen,the Netherlands. It offers a wide range of medical services, including emergency care, surgery, radiology, cardiology, and rehabilitation...
PR Newswire
27/06/2023

Astraveus raises €16.5 Million Series Seed round to advance the development of…

At the innovative core of Lakhesys are microfluidic bioprocessors, which mimic organ perfusion and significantly accelerate the molecular exchanges needed to sustain and transform cells into potent therapeutic agents. The high degree of precision and miniaturization enabled by microfluidic bioprocessors allow more efficient manufacturing, reducing labour, floor space and energy requirements, thereby generating less waste and making the process far cheaper and greener. At the innovative core…
PR Newswire
27/06/2023

Press Release: Positive topline Phase 2b data in atopic dermatitis support…

Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligandmonoclonal antibody Amlitelimab shows statistically significant improvements in signs and symptoms of moderate-to-severe atopic dermatitis in adultsStudy met its primary endpoint of percentage change in Eczema Area and Severity Index score from baseline at 16 weeks, with continued improvement seen through...
Nasdaq GlobeNewswire
27/06/2023

Kinarus Therapeutics signed subordinated bridge loans to ensure further…

Basel, Switzerland, June 26 , 2023– Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and ophthalmic diseases, today announced the signing of subordinated bridge loan agreements with existing shareholders to ensure further liquidity is available to Kinarus during the period of time required for bridging the pending transfer of funds pursuant to a CHF1.5 million convertible loan...
Nasdaq GlobeNewswire
27/06/2023

Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum…

Key Takeaways from the Antibody-drug Conjugates Competitive Landscape Report Key Takeaways from the Antibody-drug Conjugates Competitive Landscape Report Request a sample and discover the recent advances in antibody-drug conjugates treatment @Antibody-drug Conjugates Competitive Landscape Report Antibody-drug Conjugates Overview Antibody-drug conjugates (ADC) are one of the most rapidly increasing anticancer treatments. This method uses a mAb attached to a lethal payload via...
PR Newswire
26/06/2023

ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

ERYTECH and PHERECYDES announce mergerand name change to PHAXIAM Therapeutics Merger approved with large majority by the shareholders of both companiesNew governance structure implementedAmbition to create a global leader in extended phage therapies to target antimicrobial resistant pathogenic bacteriaLyon (France) and Cambridge (MA, US), June 26, 2023–ERYTECH (Nasdaq & Euronext: ERYP) and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a...
Nasdaq GlobeNewswire
26/06/2023
Altri  Comunicati